Diabetes Mellitus, Type 2 Clinical Trial
Official title:
Evaluating a Digital Diabetes Education Program Based on Individualized Carbohydrate Management
The first line of treatment for patients with type 2 diabetes usually entails referral for
diabetes education which has been shown to improve outcomes. The National Diabetes Audit
2016-17 showed an increase in the percentage of patients with type 2 diabetes who are offered
a diabetes education program. Despite this, the percentage of recorded attendance was only
7%.
Digitally delivered interventions have the potential to solve the problem of adherence to
education programs. Digitally delivered diabetes prevention programs have been shown to have
higher participation than in-person programs. As a solution to this we propose a structured
diabetes education program based on individualized carbohydrate management delivered through
a mobile application. The clinical approach is based on multiple clinical trials
demonstrating its effectiveness and is in line with the most recent NICE guidelines.
The investigator interviewed a group of general practitioners and patients to identify the
target group most suited for this solution. Three groups of patients were identified who
would benefit the most from a digital diabetes education program. The first group are
patients who have declined face-to-face education for any reason. The second group are
patients who are on a waiting list for face-to-face education but will not receive it. The
third group are patients who have undergone in-person education but have not clinically
improved.
To evaluate the acceptability of this approach among patients with diabetes type 2 the
investigators will use a Net Promoter Score survey. Adherence to the program will be assessed
by measuring the percentage of people completing the whole 3 months. We will also evaluate
whether this approach improves patient outcomes as measured by NICE defined treatment targets
for glucose control, blood pressure and blood cholesterol. Secondary aims include comparing
healthcare resource utilization. Outcomes are to be measured at baseline and at the
completion of the 12 week program. Clinical outcomes to be measured are: body weight, blood
pressure, Haemoglobin A1c (HbA1c), total cholesterol, low-density lipoprotein cholesterol,
high-density lipoprotein cholesterol and triglycerides level.
In 2019 the Secretary of State for Health and Social Care commissioned The Topol Review:
Preparing the healthcare workforce to deliver the digital future which recommended the
adoption of digital medicine to improve National Health Service (NHS) services and face the
future challenges facing the NHS. Among these challenges is the increasingly alarming burden
of type 2 diabetes mellitus (T2DM) on the NHS with more than 4 million people diagnosed with
disease and 12 million with pre-diabetes across the United Kingdom (UK). The National
Institute of Clinical Excellence (NICE) encourages the adoption of individualized approaches
to diabetes care that are tailored to the needs of patients with type 2 diabetes through
structured education programs that are evidence based.
Standard practice across the UK is to offer patient with T2DM face-to-face structured
education such as DESMOND (Diabetes Education and Self-Management for On-going and Newly
Diagnosed) and the X-pert Health program. These programs follow a face-to-face structured
group education session format.
The National Diabetes Audit 2016-17 showed an increase in the percentage of patients with
T2DM who are offered a diabetes education program with more ore than 90% of people diagnosed
with T2DM being offered structured education. Despite this, only 7% of these patients
recorded an attendance.
Digitally delivered interventions have the potential to solve the problem of adherence to
education programs. Digitally delivered diabetes prevention programs have been shown to have
higher participation than in-person programs. The digital nature of these interventions
allows them to be delivered at scale and at a lower cost when compared to in-person programs.
NICE puts great emphasis on individualization of recommendations delivered to patients.
The investigators propose a digitally delivered diabetes education program based on
individualization of carbohydrate intake through regular interactions with a trained
nutritionist via text messaging. The program follows a clinical approach based on
low-carbohydrate and low glycemic index diet recommendations which has been shown to have
better participant retention, greater weight loss and better T2DM outcomes when compared to
other dietary approaches. It is also in line with the latest National Institute for Health
and Care Excellence (NICE) guidelines and recommendations.
The investigators interviewed a group of general practitioners and patients to identify the
target group most suited for this solution. Three groups of patients were identified who
would benefit the most from a digital diabetes education program. The first group are
patients who have declined face-to-face education for any reason. The second group are
patients who are on a waiting list for face-to-face education but will not receive it. The
third group are patients who have undergone in-person education but have not clinically
improved.
Participants will be invited to download the Span Health mobile application (app). The app
delivers educational content on diabetes and nutrition in a structured format in a 12 week
long program.
Participants will be invited to have a 1-to-1 consultation with a nutritionist through the
app at the beginning of the program where they will set goals and expectations and a
nutritional plan. They will have weekly consultations to track their progress. The app also
allows participants to ask questions via text messaging at any time which would be directed
to a nutritionist who will provide an answer.
The app allows for personal tracking of self-measured blood glucose and ketone levels. It
also contains tools for fasting tracking and nutritional information on common foods along
with a library of food recipes.
The Span Health program is based on individualized carbohydrate management which aims to
train participants to adopt a low-carbohydrate diet taking into account the patient's
self-measured biometrics and individual tolerances and circumstances.
To evaluate the acceptability of this approach among patients with diabetes type 2 the
investigators will conduct a single arm non-randomised controlled trial recruiting a number
of patients to use the service. Qualitative outcomes will be measured using a Net Promoter
Score survey based on a 0 to 10 scale with a higher score indicating a more favorable
outcome. Adherence to the program will be assessed by measuring the percentage of people
completing the whole 3 months. They will also evaluate whether this approach improves patient
outcomes as measured by NICE defined treatment targets for glucose control, blood pressure
and blood cholesterol. Outcomes are to be measured at baseline and at the completion of the
12 week program. Clinical outcomes to be measured are: body weight, blood pressure, fasting
blood glucose, Haemoglobin A1c (HbA1c), total cholesterol, low-density lipoprotein
cholesterol, high-density lipoprotein cholesterol and triglycerides level.
Despite the increasing availability of digitally delivered diabetes education programs, most
practices still offer in-person programs. Which the increasing burden of diabetes on the NHS.
it is wise to start thinking about more scalable solutions that utilize digital medicine to
approach this problem. This relatively novel approach if proven to be beneficial could lead
to wider studies and a discussion on changing the current approach recommended by NICE.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT05666479 -
CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery
|
||
| Completed |
NCT05647083 -
The Effect of Massage on Diabetic Parameters
|
N/A | |
| Active, not recruiting |
NCT05661799 -
Persistence of Physical Activity in People With Type 2 Diabetes Over Time.
|
N/A | |
| Completed |
NCT03686722 -
Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin
|
Phase 1 | |
| Completed |
NCT02836704 -
Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose)
|
Phase 4 | |
| Completed |
NCT01819129 -
Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes
|
Phase 3 | |
| Completed |
NCT04562714 -
Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Insulin Antihyperglycemic Therapy
|
N/A | |
| Completed |
NCT02009488 -
Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM)
|
Phase 1 | |
| Completed |
NCT05896319 -
Hyaluronic Acid Treatment of the Post-extraction Tooth Socket Healing in Subjects With Diabetes Mellitus Type 2
|
N/A | |
| Recruiting |
NCT05598203 -
Effect of Nutrition Education Groups in the Treatment of Patients With Type 2 Diabetes
|
N/A | |
| Completed |
NCT05046873 -
A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People
|
Phase 1 | |
| Terminated |
NCT04090242 -
Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes
|
N/A | |
| Completed |
NCT04030091 -
Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus
|
Phase 4 | |
| Completed |
NCT03604224 -
A Study to Observe Clinical Effectiveness of Canagliflozin 300 mg Containing Treatment Regimens in Indian Type 2 Diabetes Participants With BMI>25 kg/m^2, in Real World Clinical Setting
|
||
| Completed |
NCT03620357 -
Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D)
|
N/A | |
| Completed |
NCT01696266 -
An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
|
||
| Completed |
NCT03620890 -
Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy
|
Phase 4 | |
| Withdrawn |
NCT05473286 -
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice
|
||
| Not yet recruiting |
NCT05029804 -
Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes
|
N/A | |
| Completed |
NCT04531631 -
Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic Diabetes
|
Phase 2 |